562
Views
12
CrossRef citations to date
0
Altmetric
Review

Antipsychotic medication, functional outcome and quality of life in schizophrenia: focus on amisulpride

&
Pages 787-801 | Accepted 22 Dec 2009, Published online: 03 Feb 2010

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Tanja Veselinović, Ingo Vernaleken, Paul Cumming, Uwe Henning, Lina Winkler, Peter Kaleta, Michael Paulzen, Christian Luckhaus & Gerhard Gründer. (2018) Antidopaminergic medication in healthy subjects provokes subjective and objective mental impairments tightly correlated with perturbation of biogenic monoamine metabolism and prolactin secretion. Neuropsychiatric Disease and Treatment 14, pages 1125-1138.
Read now

Articles from other publishers (11)

Valeria S. Serazetdinova, Natalia N. Petrova, Larisa G. Serazetdinova & Lyubov Ya. Gluskina. (2022) Gender characteristics of schizophrenia remission. Neurology Bulletin LIV:3, pages 11-20.
Crossref
Rajamanikandan Savarimalai, Aarti Jagannathan, Soyuz John, Shanivaram K. Reddy & Dhanashekara Pandian. (2020) Biopsychosocial Approach for Improving the Quality Life of Persons with Mental Illness: A Case Report from India. Journal of Psychosocial Rehabilitation and Mental Health 8:1, pages 81-87.
Crossref
George Awad, Daisy Ng-Mak, Krithika Rajagopalan, Jay Hsu, Andrei Pikalov & Antony Loebel. (2016) Long-term health-related quality of life improvements among patients treated with lurasidone: results from the open-label extension of a switch trial in schizophrenia. BMC Psychiatry 16:1.
Crossref
Andrea de Bartolomeis, Federica Marmo, Elisabetta F. Buonaguro, Gianmarco Latte, Carmine Tomasetti & Felice Iasevoli. (2016) Switching antipsychotics: Imaging the differential effect on the topography of postsynaptic density transcripts in antipsychotic-naïve vs. antipsychotic-exposed rats. Progress in Neuro-Psychopharmacology and Biological Psychiatry 70, pages 24-38.
Crossref
John M. Kane, Stephen Zukin, Yao Wang, Kaifeng Lu, Adam Ruth, Krisztián Nagy, István Laszlovszky & Suresh Durgam. (2015) Efficacy and Safety of Cariprazine in Acute Exacerbation of Schizophrenia. Journal of Clinical Psychopharmacology 35:4, pages 367-373.
Crossref
Mark J. Millan, Kevin Fone, Thomas Steckler & William P. Horan. (2014) Negative symptoms of schizophrenia: Clinical characteristics, pathophysiological substrates, experimental models and prospects for improved treatment. European Neuropsychopharmacology 24:5, pages 645-692.
Crossref
T Godoy, A Riva & J Ekström. (2012) Atypical antipsychotics - effects of amisulpride on salivary secretion and on clozapine-induced sialorrhea. Oral Diseases 18:7, pages 680-691.
Crossref
Somayeh Jafari, Francesca Fernandez‐Enright & Xu‐Feng Huang. (2011) Structural contributions of antipsychotic drugs to their therapeutic profiles and metabolic side effects. Journal of Neurochemistry 120:3, pages 371-384.
Crossref
Amresh Shrivastava, Megan Johnston, Kristen Terpstra, Larry Stitt & Nilesh Shah. (2012) Atypical antipsychotics usage in long-term follow-up of first episode schizophrenia. Indian Journal of Psychiatry 54:3, pages 248.
Crossref
Gerhard Gross & Karla Drescher. 2012. Novel Antischizophrenia Treatments. Novel Antischizophrenia Treatments 167 210 .
Adrian Newman-Tancredi & Mark S. Kleven. (2011) Comparative pharmacology of antipsychotics possessing combined dopamine D2 and serotonin 5-HT1A receptor properties. Psychopharmacology 216:4, pages 451-473.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.